Accordingly, systemic administration of siRNA‐lipoplex (Atu027) directed against PKN3 and targeting mainly the stromal compartment rather than the pathologically defined tumor entity, prevented lung metastasis in lung experimental and spontaneous breast metastasis models in a dose‐dependent manner (Santel et al., 2010). Here, PKN3 is linked to neoplasm.